Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Not yet recruiting 3Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Neoplasms 1Motor Activity 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Cachexia 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Accelerometry × Clear all
NCT05188755 2022-12-23

CUPCAKE

University Hospital, Clermont-Ferrand

Phase NA Completed
44 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Motor Activity

NCT02500004 2018-08-03

BAT-Cachexia

Maastricht University Medical Center

Phase NA Completed
16 enrolled
Gastrointestinal

Cachexia, Neoplasms, Pancreatic Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡